CN110382718A - 用于指示具有特定特征的个体中的前列腺癌的存在或不存在的方法 - Google Patents

用于指示具有特定特征的个体中的前列腺癌的存在或不存在的方法 Download PDF

Info

Publication number
CN110382718A
CN110382718A CN201880009454.1A CN201880009454A CN110382718A CN 110382718 A CN110382718 A CN 110382718A CN 201880009454 A CN201880009454 A CN 201880009454A CN 110382718 A CN110382718 A CN 110382718A
Authority
CN
China
Prior art keywords
pca
individual
pcags
psa
snp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201880009454.1A
Other languages
English (en)
Chinese (zh)
Inventor
H.格伦贝格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fadia Co Ltd
Original Assignee
Fadia Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fadia Co Ltd filed Critical Fadia Co Ltd
Publication of CN110382718A publication Critical patent/CN110382718A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B10/00—ICT specially adapted for evolutionary bioinformatics, e.g. phylogenetic tree construction or analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Evolutionary Biology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physiology (AREA)
  • Software Systems (AREA)
  • Bioethics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Evolutionary Computation (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Artificial Intelligence (AREA)
CN201880009454.1A 2017-02-01 2018-02-01 用于指示具有特定特征的个体中的前列腺癌的存在或不存在的方法 Pending CN110382718A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1750080 2017-02-01
SE1750080-2 2017-02-01
PCT/EP2018/052473 WO2018141828A1 (en) 2017-02-01 2018-02-01 Method for indicating a presence or non-presence of prostate cancer in individuals with particular characteristics

Publications (1)

Publication Number Publication Date
CN110382718A true CN110382718A (zh) 2019-10-25

Family

ID=61188779

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880009454.1A Pending CN110382718A (zh) 2017-02-01 2018-02-01 用于指示具有特定特征的个体中的前列腺癌的存在或不存在的方法

Country Status (7)

Country Link
US (1) US20190345565A1 (enExample)
EP (1) EP3577237B1 (enExample)
JP (2) JP7138112B2 (enExample)
CN (1) CN110382718A (enExample)
DK (1) DK3577237T3 (enExample)
FI (1) FI3577237T3 (enExample)
WO (1) WO2018141828A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6678201B2 (ja) * 2018-06-05 2020-04-08 日清食品ホールディングス株式会社 食品情報提供システム、装置、方法及びプログラム
GB2599198B (en) * 2021-06-15 2022-12-07 A3P Biomedical Ab A method for determining an appropriate time interval for further diagnostic testing for prostate cancer
CA3250931A1 (en) * 2022-04-27 2023-11-02 Genetic Tech Limited METHODS FOR ASSESSING THE RISK OF DEVELOPING PROSTATE CANCER

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012031207A2 (en) * 2010-09-03 2012-03-08 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
WO2012029080A1 (en) * 2010-08-30 2012-03-08 Decode Genetics Ehf Sequence variants associated with prostate specific antigen levels
WO2013172779A2 (en) * 2012-05-16 2013-11-21 Phadia Ab Method for indicating the presence or non-presence of prostate cancer
WO2014079865A1 (en) * 2012-11-20 2014-05-30 Phadia Ab Method for indicating a presence or non-presence of aggressive prostate cancer
CA3134289A1 (en) * 2014-03-11 2015-09-17 Phadia Ab Method for detecting a solid tumor cancer
CN104946786A (zh) * 2015-07-21 2015-09-30 冯宁翰 一种检测前列腺癌易感性的方法及试剂盒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030219840A1 (en) 2002-05-24 2003-11-27 Mikolajczyk Stephen D. Method of analyzing proenzyme forms of prostate specific antigen in serum to improve prostate cancer detection
EP2089548A1 (en) 2006-10-27 2009-08-19 Decode Genetics EHF Cancer susceptibility variants on chr8q24.21
US20120021925A1 (en) 2009-01-19 2012-01-26 Miraculins, Inc. Diagnostic assays for prostate cancer using psp94 and psa biomarkers
JP2016508026A (ja) * 2012-11-20 2016-03-17 ファディア・アクチボラゲットＰｈａｄｉａ ＡＢ 前立腺癌を有する個体の予後診断方法

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012029080A1 (en) * 2010-08-30 2012-03-08 Decode Genetics Ehf Sequence variants associated with prostate specific antigen levels
WO2012031207A2 (en) * 2010-09-03 2012-03-08 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
WO2013172779A2 (en) * 2012-05-16 2013-11-21 Phadia Ab Method for indicating the presence or non-presence of prostate cancer
WO2014079865A1 (en) * 2012-11-20 2014-05-30 Phadia Ab Method for indicating a presence or non-presence of aggressive prostate cancer
CN105051206A (zh) * 2012-11-20 2015-11-11 法迪亚股份有限公司 用于指示侵袭性前列腺癌的存在或不存在的方法
CA3134289A1 (en) * 2014-03-11 2015-09-17 Phadia Ab Method for detecting a solid tumor cancer
CN104946786A (zh) * 2015-07-21 2015-09-30 冯宁翰 一种检测前列腺癌易感性的方法及试剂盒

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
J. GUDMUNDSSON等: "Genetic Correction of PSA Values Using Sequence Variants Associated with PSA Levels", 《SCIENCE TRANSLATIONAL MEDICINE》 *
J. GUDMUNDSSON等: "Genetic Correction of PSA Values Using Sequence Variants Associated with PSA Levels", 《SCIENCE TRANSLATIONAL MEDICINE》, 15 December 2010 (2010-12-15) *
MARKUS ALY等: "Polygenic Risk Score Improves Prostate Cancer Risk Prediction: Results from the Stockholm-1 Cohort Study", 《EUROPEAN UROLOGY》 *
MARKUS ALY等: "Polygenic Risk Score Improves Prostate Cancer Risk Prediction: Results from the Stockholm-1 Cohort Study", 《EUROPEAN UROLOGY》, 8 January 2011 (2011-01-08) *

Also Published As

Publication number Publication date
EP3577237A1 (en) 2019-12-11
WO2018141828A1 (en) 2018-08-09
DK3577237T3 (da) 2023-08-28
JP2022179483A (ja) 2022-12-02
FI3577237T3 (fi) 2023-08-29
JP7138112B2 (ja) 2022-09-15
US20190345565A1 (en) 2019-11-14
EP3577237B1 (en) 2023-07-19
JP2020505928A (ja) 2020-02-27

Similar Documents

Publication Publication Date Title
AU2013349801B2 (en) Method for indicating a presence or non-presence of aggressive prostate cancer
RU2720148C9 (ru) Способ обнаружения солидной злокачественной опухоли
US20200010912A1 (en) Prognostic method for individuals with prostate cancer
US20150094221A1 (en) Method for Indicating the Presence or Non-Presence of Prostate Cancer
JP2022179483A (ja) 特定の特徴を有する個体において前立腺癌の存在または不存在を示すための方法
CN105051206B (zh) 用于指示侵袭性前列腺癌的存在或不存在的方法
HK1215594B (en) Method for indicating a presence or non-presence of aggressive prostate cancer

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20191025

RJ01 Rejection of invention patent application after publication